Minor
Ranibizumab 10mg/ml Injection (Incepta) · Diabetic Macular Edema
Trial completed
Also in this update: Primary completion date changed from estimate of Oct 2025 to Mar 10, 2026
Incepta Pharmaceuticals LtdPhase 3 NCT06305416 Registry history of NCT06305416 on ClinicalTrials.gov (opens the registry)